The current valuation score of Journey Medical Corp is 9.12, ranking 46 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -18.20, which is -355.14% below the recent high of 46.43 and -91.29% above the recent low of -34.81.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.